Prostate Cancer - Results from #20740

Biomarkers in prostate cancer: What's new? - Abstract April 18, 2014

Underutilization of local salvage therapy after radiation therapy for prostate cancer - Abstract April 18, 2014

Imaging modalities in focal therapy: Patient selection, treatment guidance, and follow-up - Abstract April 18, 2014

Evaluation of time, attendance of medical staff, and resources during interstitial brachytherapy for prostate cancer : DEGRO-QUIRO trial - Abstract April 18, 2014

Androgen receptor antagonists for prostate cancer therapy - Abstract April 18, 2014

Online report in real time from the National Prostate Cancer Register (NPCR) of Sweden, a new and efficient tool for quality assurance - Abstract April 18, 2014

Feedback on baseline use of staging images is important to improve image overuse with newly diagnosed prostate cancer patients - Abstract April 18, 2014

Preclinical evaluation of imaging biomarkers for prostate cancer bone metastasis and response to cabozantinib - Abstract April 18, 2014

What should we tell prostate cancer patients about (secondary) prevention? - Abstract April 18, 2014

A volumetric approach to path-length measurements is essential when treating radiotherapy with modulated beams - Abstract April 18, 2014

Impact of probe pressure variability on prostate localization for ultrasound-based image-guided radiotherapy - Abstract April 18, 2014

Prior-cancer diagnosis in men with nonmetastatic prostate cancer and the risk of prostate-cancer-specific and all-cause mortality - Abstract April 18, 2014

Obligatory information that a patient diagnosed of prostate cancer and candidate for an active surveillance protocol must know - Abstract April 18, 2014

Tissue biomarkers for prognosis of prostate cancer: A systematic review and meta-analysis - Abstract April 18, 2014

Focal radiotherapy as focal therapy of prostate cancer - Abstract April 18, 2014

What is still needed to make focal therapy an accepted segment of standard therapy? - Abstract April 18, 2014

Living with untreated prostate cancer: Predictors of quality of life - Abstract April 17, 2014

Prevention of bone metastases in patients with high-risk nonmetastatic prostate cancer treated with zoledronic acid: Efficacy and safety results of the Zometa European Study (ZEUS) - Abstract April 17, 2014

How to select the right patients for focal therapy of prostate cancer? - Abstract April 17, 2014

The influence of prostate volume on cancer detection in the Chinese population - Abstract April 17, 2014

Page 1038 of 1435